AAAAAA
Results: 1-25/85
Authors:
DIMOPOULOS MA
PAPADOPOULOU M
ANDREOPOULOU E
PAPADIMITRIOU C
PAVLIDIS N
ARAVANTINOS G
ASPROPOTAMITIS A
FOUNTZILAS G
MICHALAS S
PECTASIDES D
Citation: Ma. Dimopoulos et al., FAVORABLE OUTCOME OF OVARIAN GERM-CELL MALIGNANCIES TREATED WITH CISPLATIN OR CARBOPLATIN BASED CHEMOTHERAPY - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, European journal of cancer, 34, 1998, pp. 103-103
Authors:
ARAVANTINOS G
FOUNTZILAS G
KOSMIDES P
STATHOPOULOS GP
PAVLIDIS N
DIMOPOULOS MA
BAFALOUKOS D
PAPAKOSTAS P
PAPADIMITRIOU C
NIKOLAIDES G
SKARLOS DV
Citation: G. Aravantinos et al., COMBINATION PACLITAXEL PLUS CARBOPLATIN VERSUS PACLITAXEL WITH ALTERNATING CARBOPLATIN AND CISPLATIN AS FIRST LINE TREATMENT FOR ADVANCED OVARIAN-CANCER (AOC), Annals of oncology, 9, 1998, pp. 316-316
Authors:
DIMOPOULOS MA
PAPADOPOULOU M
ANDREOPOULOU E
PAPADIMITRIOU C
PAVLIDIS N
ARAVANTINOS G
ASPROPORAMITIS A
ANAGNOSTOPOULOS A
FOUNTZILAS G
ATHANASSIADES P
PECTACIDES D
Citation: Ma. Dimopoulos et al., FAVORABLE OUTCOME OF OVARIAN GERM-CELL MALIGNANCIES TREATED WITH CISPLATIN OR CARBOPLATIN-BASED CHEMOTHERAPY, Annals of oncology, 9, 1998, pp. 343-343
Authors:
PAPADIMITRIOU C
DIMOPOULOS MA
MOULOPOULOS L
SARRIS K
FOUNTZILAS G
VOULGARIS Z
ANAGNOSTOPOULOS A
ATHANASSIADES P
STAMATELOPOULOS S
Citation: C. Papadimitriou et al., A PHASE-II TRIAL OF PACLITAXEL AND CISPLATIN IN THE TREATMENT OF METASTATIC CARCINOMA OF THE UTERINE CERVIX, Annals of oncology, 9, 1998, pp. 350-350
Authors:
GEORGOULIAS V
KOUROUSIS C
KAKOLYRIS S
DIMOPOULOS MA
PAPADAKIS E
APOSTOLOPULOU F
AGELIDOU A
TZIANNI V
SARRA E
VARDAKIS N
Citation: V. Georgoulias et al., FRONT-LINE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER WITH DOCETAXEL AND GEMCITABINE - A MULTICENTER PHASE-II TRIAL, Annals of oncology, 9, 1998, pp. 453-453
Authors:
SFIKAKIS PP
DIMOPOULOS MA
SOULIOTIS VL
CHARALAMBOPOULOS D
MAVRIKAKIS M
PANAYIOTIDIS P
Citation: Pp. Sfikakis et al., EFFECTS OF 2-CHLORODEOXYADENOSINE AND GOLD SODIUM THIOMALATE ON HUMANBCL-2 GENE-EXPRESSION, Immunopharmacology and immunotoxicology, 20(1), 1998, pp. 63-77
Authors:
FOUNTZILAS G
ATHANASSIADES A
PAPADIMITRIOU V
DIMOPOULOS MA
BAFALOUKOS D
ARAVANTINOS G
NICOLAIDES C
KALOFONOS HR
PAPAKOSTAS P
XIROS N
RAZI E
Citation: G. Fountzilas et al., PACLITAXEL AND CARBOPLATIN AS FIRST-LINE CHEMOTHERAPY FOR ADVANCED BREAST-CANCER, Oncology, 12(1), 1998, pp. 45-48
Authors:
DIMOPOULOS MA
MOULOPOULOS LA
Citation: Ma. Dimopoulos et La. Moulopoulos, ROLE OF ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF INVASIVE-CARCINOMA OF THE URINARY-BLADDER, Journal of clinical oncology, 16(4), 1998, pp. 1601-1612
Authors:
BERENSON JR
LICHTENSTEIN A
PORTER L
DIMOPOULOS MA
BORDONI R
GEORGE S
LIPTON A
KELLER A
BALLESTER O
KOVACS M
BLACKLOCK H
BELL R
SIMEONE JF
REITSMA DJ
HEFFERNAN M
SEAMAN J
KNIGHT RD
Citation: Jr. Berenson et al., LONG-TERM PAMIDRONATE TREATMENT OF ADVANCED MULTIPLE-MYELOMA PATIENTSREDUCES SKELETAL EVENTS, Journal of clinical oncology, 16(2), 1998, pp. 593-602
Authors:
DIMOPOULOS MA
PAPADOPOULOU M
ANDREOPOULOU E
PAPADIMITRIOU C
PAVLIDIS N
ARAVANTINOS G
ASPROPOTAMITIS A
ANAGNOSTOPOULOS A
FOUNTZILAS G
MICHALAS S
PECTACIDES D
Citation: Ma. Dimopoulos et al., FAVORABLE OUTCOME OF OVARIAN GERM-CELL MALIGNANCIES TREATED WITH CISPLATIN OR CARBOPLATIN-BASED CHEMOTHERAPY - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Gynecologic oncology (Print), 70(1), 1998, pp. 70-74
Authors:
DIMOPOULOS MA
DELIVELIOTIS C
MOULOPOULOS LA
PAPADIMITRIOU C
MITROPOULOS D
ANAGNOSTOPOULOS A
ATHANASSIADES P
DIMOPOULOS C
Citation: Ma. Dimopoulos et al., TREATMENT OF PATIENTS WITH METASTATIC UROTHELIAL CARCINOMA AND IMPAIRED RENAL-FUNCTION WITH SINGLE-AGENT DOCETAXEL, Urology, 52(1), 1998, pp. 56-60
Authors:
PANTAZOPOULOS D
KARAKITSOS P
POULIAKIS A
IOKIMLIOSSI A
DIMOPOULOS MA
Citation: D. Pantazopoulos et al., STATIC CYTOMETRY AND NEURAL NETWORKS IN THE DISCRIMINATION OF LOWER URINARY SYSTEM LESIONS, Urology, 51(6), 1998, pp. 946-950
Authors:
NAKOPOULOU L
VOURLAKOU C
ZERVAS A
TZONOU A
GAKIOPOULOU H
DIMOPOULOS MA
Citation: L. Nakopoulou et al., THE PREVALENCE OF BCL-2, P53, AND KI-67 IMMUNOREACTIVITY IN TRANSITIONAL-CELL BLADDER CARCINOMAS AND THEIR CLINICOPATHOLOGICAL CORRELATES, Human pathology, 29(2), 1998, pp. 146-154
Authors:
PAPADIMITRIOU CA
DIMOPOULOS MA
AMPELA C
LOUVROUFERTAKI A
ANAGNOSTOPOULOS A
ATHANASSIADES P
STAMATELOPOULOS S
KERAMOPOULOS A
Citation: Ca. Papadimitriou et al., SEQUENTIAL ADMINISTRATION OF DOXORUBICIN AND PACLITAXEL FOLLOWED BY CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL COMBINATION (CMF) IN WOMEN WITH METASTATIC BREAST-CANCER, Oncology, 55(6), 1998, pp. 533-537
Authors:
DIMOPOULOS MA
Citation: Ma. Dimopoulos, HIGH-DOSE THERAPY IN MULTIPLE-MYELOMA, British Journal of Haematology, 102(1), 1998, pp. 142-143
Authors:
DIMOPOULOS MA
KOSTIS E
ANAGNOSTOPOULOS A
DALEZIOS M
PAPADIMITRIS C
PAPADIMITRIOU C
Citation: Ma. Dimopoulos et al., VERY LATE RELAPSE OF HODGKINS-DISEASE AFTER 24 YEARS OF COMPLETE REMISSION, Leukemia & lymphoma, 28(1-2), 1997, pp. 215-217
Authors:
SARRIS AH
PAPADIMITRAKOPOULOU V
DIMOPOULOS MA
SMITH T
PUGH W
HA CS
MCLAUGHLIN P
CALLENDER D
COX J
CABANILLAS F
Citation: Ah. Sarris et al., PRIMARY PAROTID LYMPHOMA - THE EFFECT OF INTERNATIONAL PROGNOSTIC INDEX ON OUTCOME, Leukemia & lymphoma, 26(1-2), 1997, pp. 49-56
Authors:
DIMOPOULOS MA
THEODORAKIS M
KOSTIS E
PAPADIMITRIS C
MOULOPOULOS LA
ANASTASIOUNANA M
Citation: Ma. Dimopoulos et al., TREATMENT OF LANGERHANS CELL HISTIOCYTOSIS WITH 2-CHLORODEOXYADENOSINE, Leukemia & lymphoma, 25(1-2), 1997, pp. 187-189
Authors:
BACOYIANNIS C
DIMOPOULOS MA
NICOLAIDES C
ARAVANTINOS G
XIROS N
SKARLOS D
PAVLIDIS N
KOSMIDIS P
Citation: C. Bacoyiannis et al., PHASE-II STUDY OF INTERFERON-GAMMA (RIFN-G) AND VINBLASTINE (VBL) IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA (RCC), European journal of cancer, 33, 1997, pp. 177-177
Authors:
PAPADIMITRIOU CA
DIMOPOULOS MA
GIANNAKOULIS N
SARRIS K
VASSILAKOPOULOS G
AKRIVOS T
VOULGARIS Z
VLAHOS G
ATHANASSIADIS P
Citation: Ca. Papadimitriou et al., A PHASE-II TRIAL OF METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN (MVAC) IN METASTATIC CANCER OF THE UTERINE CERVIX, European journal of cancer, 33, 1997, pp. 961-961
Authors:
KAKOLYRIS S
KOUROUSIS C
ANDROULAKIS N
DIMOPOULOS MA
PAPADAKIS E
TZANNES S
KOTSAKIS T
VARDAKIS N
MERAMBELIOTAKIS N
KALBAKIS C
XATZIDAKI D
GEORGOULIAS V
Citation: S. Kakolyris et al., 2ND LINE TREATMENT OF NONSMALL CELL LUNG-CANCER WITH PACLITAXEL AND GEMCITABINE, European journal of cancer, 33, 1997, pp. 1049-1049
Authors:
DIMOPOULOS MA
PAPADIMITRIOU C
GENNATAS C
AKRIVOS T
VLAHOS G
VOULGARIS Z
DIACOMANOLIS E
ATHANASSIADES P
MIHALAS S
Citation: Ma. Dimopoulos et al., IFOSFAMIDE AND PACLITAXEL SALVAGE CHEMOTHERAPY FOR ADVANCED EPITHELIAL OVARIAN-CANCER, Annals of oncology, 8(2), 1997, pp. 195-197
Authors:
SARRIS AH
LUTHRA R
PAPADIMITRACOPOULOU V
WAASDORP M
DIMOPOULOS MA
MCBRIDE JA
CABANILLAS F
DUVIC M
DEISSEROTH A
MORRIS SW
PUGH WC
Citation: Ah. Sarris et al., LONG-RANGE AMPLIFICATION OF GENOMIC DNA DETECTS THE T(2-5)(P23-Q35) IN ANAPLASTIC LARGE-CELL LYMPHOMA, BUT NOT IN OTHER NON-HODGKINS-LYMPHOMAS, HODGKINS-DISEASE, OR LYMPHOMATOID PAPULOSIS, Annals of oncology, 8, 1997, pp. 59-63
Authors:
GEORGOULIAS V
KOUROUSIS C
ANDROULAKIS N
KAKOLYRIS S
DIMOPOULOS MA
BOUROS D
PAPADIMITRIOU C
HATZAKIS K
HERAS P
KALBAKIS K
KOTSAKIS T
VARDAKIS N
MERAMVELIOTAKIS N
HATZIDAKI D
Citation: V. Georgoulias et al., DOCETAXEL (TAXOTERE) AND GEMCITABINE IN THE TREATMENT OF NONSMALL CELL LUNG-CANCER - PRELIMINARY-RESULTS, Seminars in oncology, 24(4), 1997, pp. 22-25
Authors:
GEORGOULIAS V
KOUROUSIS C
KAKOLYRIS S
ANDROULAKIS N
DIMOPOULOS MA
PAPADAKIS E
KOTSAKIS T
VARDAKIS N
KALBAKIS K
MERAMBELIOTAKIS N
HATZIDAKI D
Citation: V. Georgoulias et al., 2ND-LINE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER WITH PACLITAXEL AND GEMCITABINE - A PRELIMINARY-REPORT ON AN ACTIVE REGIMEN, Seminars in oncology, 24(4), 1997, pp. 61-66